Generated: May 29, 2017
|Abstract:||The present invention relates to antiviral therapies and compositions for treating or preventing Hepatitis C infections in patients and relates to other methods disclosed herein. The invention also relates to kits and pharmaceutical packs comprising compositions and dosage forms. The invention also relates to processes for preparing these compositions, dosages, kits, and packs.|
|Inventor(s):||Chu; Hui-May (Natick, MA), Ette; Ene (Framingham, MA), McNair; Lindsay (Allston, MA), Alam; John (Cambridge, MA)|
|Assignee:||Vertex Pharmaceuticals Incorporated (Cambridge, MA)|
1. A therapeutic regimen comprising administering for a period of at least 14 days: a. VX-950, or a pharmaceutically acceptable salt thereof, three times per day in an amount of about
750 mg; b. pegylated interferon in an amount of about 180 .mu.g/wk; and c. ribavirin.
2. The regimen of claim 1, wherein the amount of VX-950 is administered every 8 hours.